On August 24, 2020 Navidea Biopharmaceuticals, Inc. (NYSE American:NAVB) ("Navidea" or the "Company"), a company focused on the development of precision immunodiagnostic agents and immunotherapeutics, reported that Mr. Jed Latkin, Chief Executive Officer, will present at the LD Micro 500 investor conference (Press release, Navidea Biopharmaceuticals, AUG 24, 2020, View Source [SID1234563977]). The virtual conference will be held on September 1-4, 2020. Mr. Latkin will present on Tuesday, September 1 at 4:40 p.m. EDT in Track 4, which will be webcast.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Details of Navidea’s presentation are below. For those who wish to listen to the live webcast, please use the following link: View Source." target="_blank" title="View Source." rel="nofollow">View Source The webcast will be archived on Navidea’s investor relations website, View Source for 90 days following the live presentation.

Event: LD 500 Virtual Investor Conference
Date: Tuesday, September 1, 2020
Time: 4:40 p.m. EDT
Webcast: View Source